UGT2B28 Accelerates Prostate Cancer Progression through Stabilization of the Endocytic Adaptor Protein HIP1 Regulating AR and EGFR Pathways

Using the Canadian Prostate Cancer Biomarker Network biobank, scientists analyzed UGT2B28 tumor expression in relation to clinical outcomes in men with localized prostate cancer.